Literature DB >> 24754704

Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling.

Mark J Ferris1, Marija Milenkovic, Shuai Liu, Catharine A Mielnik, Pieter Beerepoot, Carrie E John, Rodrigo A España, Tatyana D Sotnikova, Raul R Gainetdinov, Stephanie L Borgland, Sara R Jones, Amy J Ramsey.   

Abstract

Chronic N-methyl-d-aspartate receptor (NMDAR) hypofunction has been proposed as a contributing factor to symptoms of schizophrenia. However, it is unclear how sustained NMDAR hypofunction throughout development affects other neurotransmitter systems that have been implicated in the disease. Dopamine neuron biochemistry and activity were examined to determine whether sustained NMDAR hypofunction causes a state of hyperdopaminergia. We report that a global, genetic reduction in NMDARs led to a remodeling of dopamine neurons, substantially affecting two key regulators of dopamine homeostasis, i.e., tyrosine hydroxylase and the dopamine transporter. In NR1 knockdown mice, dopamine synthesis and release were attenuated, and dopamine clearance was increased. Although these changes would have the effect of reducing dopamine transmission, we demonstrated that a state of hyperdopaminergia existed in these mice because dopamine D2 autoreceptors were desensitized. In support of this conclusion, NR1 knockdown dopamine neurons have higher tonic firing rates. Although the tonic firing rates are higher, phasic signaling is impaired, and dopamine overflow cannot be achieved with exogenous high-frequency stimulation that models phasic firing. Through the examination of several parameters of dopamine neurotransmission, we provide evidence that chronic NMDAR hypofunction leads to a state of elevated synaptic dopamine. Compensatory mechanisms to attenuate hyperdopaminergia also impact the ability to generate dopamine surges through phasic firing.
© 2014 Federation of European Neuroscience Societies and John Wiley & Sons Ltd.

Entities:  

Keywords:  14-3-3; NMDA; burst firing; mouse; schizophrenia

Mesh:

Substances:

Year:  2014        PMID: 24754704      PMCID: PMC4331169          DOI: 10.1111/ejn.12594

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  61 in total

Review 1.  Neurotransmitter interactions in schizophrenia--therapeutic implications.

Authors:  A Carlsson; N Waters; M L Carlsson
Journal:  Biol Psychiatry       Date:  1999-11-15       Impact factor: 13.382

2.  Withdrawal from intermittent ethanol exposure increases probability of burst firing in VTA neurons in vitro.

Authors:  F Woodward Hopf; Miquel Martin; Billy T Chen; M Scott Bowers; Maysha M Mohamedi; Antonello Bonci
Journal:  J Neurophysiol       Date:  2007-08-15       Impact factor: 2.714

3.  Genetic NMDA receptor deficiency disrupts acute and chronic effects of cocaine but not amphetamine.

Authors:  Amy J Ramsey; Aki Laakso; Michel Cyr; Tatyana D Sotnikova; Ali Salahpour; Ivan O Medvedev; Linda A Dykstra; Raul R Gainetdinov; Marc G Caron
Journal:  Neuropsychopharmacology       Date:  2008-01-09       Impact factor: 7.853

4.  Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia.

Authors:  T B Halene; R S Ehrlichman; Y Liang; E P Christian; G J Jonak; T L Gur; J A Blendy; H C Dow; E S Brodkin; F Schneider; R C Gur; S J Siegel
Journal:  Genes Brain Behav       Date:  2009-05-08       Impact factor: 3.449

5.  Effects of amphetamine and desmethylimipramine on amines synthesis and release in central catecholamine-containing neurons.

Authors:  M J Besson; A Cheramy; J Glowinski
Journal:  Eur J Pharmacol       Date:  1969-07       Impact factor: 4.432

6.  NMDA-dependent modulation of CA1 local circuit inhibition.

Authors:  H C Grunze; D G Rainnie; M E Hasselmo; E Barkai; E F Hearn; R W McCarley; R W Greene
Journal:  J Neurosci       Date:  1996-03-15       Impact factor: 6.167

7.  Mutation of regulatory serines of rat tyrosine hydroxylase to glutamate: effects on enzyme stability and activity.

Authors:  Montserrat Royo; Paul F Fitzpatrick; S Colette Daubner
Journal:  Arch Biochem Biophys       Date:  2005-02-15       Impact factor: 4.013

8.  NMDA receptor hypofunction produces concomitant firing rate potentiation and burst activity reduction in the prefrontal cortex.

Authors:  Mark E Jackson; Houman Homayoun; Bita Moghaddam
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-24       Impact factor: 11.205

9.  Dissecting the contribution of individual receptor subunits to the enhancement of N-methyl-d-aspartate currents by dopamine D1 receptor activation in striatum.

Authors:  Emily L Jocoy; Véronique M André; Damian M Cummings; Shilpa P Rao; Nanping Wu; Amy J Ramsey; Marc G Caron; Carlos Cepeda; Michael S Levine
Journal:  Front Syst Neurosci       Date:  2011-05-11

10.  Isolation and structural studies on synaptic complexes from rat brain.

Authors:  C W Cotman; D Taylor
Journal:  J Cell Biol       Date:  1972-12       Impact factor: 10.539

View more
  7 in total

1.  Effects of β-Arrestin-Biased Dopamine D2 Receptor Ligands on Schizophrenia-Like Behavior in Hypoglutamatergic Mice.

Authors:  Su M Park; Meng Chen; Claire M Schmerberg; Russell S Dulman; Ramona M Rodriguiz; Marc G Caron; Jian Jin; William C Wetsel
Journal:  Neuropsychopharmacology       Date:  2015-07-01       Impact factor: 7.853

Review 2.  Applying a Fast-Scan Cyclic Voltammetry to Explore Dopamine Dynamics in Animal Models of Neuropsychiatric Disorders.

Authors:  Vladimir P Grinevich; Amir N Zakirov; Uliana V Berseneva; Elena V Gerasimova; Raul R Gainetdinov; Evgeny A Budygin
Journal:  Cells       Date:  2022-05-03       Impact factor: 7.666

3.  Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M1 PAM VU6004256.

Authors:  Michael D Grannan; Catharine A Mielnik; Sean P Moran; Robert W Gould; Jacob Ball; Zhuoyan Lu; Michael Bubser; Amy J Ramsey; Masahito Abe; Hyekyung P Cho; Kellie D Nance; Anna L Blobaum; Colleen M Niswender; P Jeffrey Conn; Craig W Lindsley; Carrie K Jones
Journal:  ACS Chem Neurosci       Date:  2016-10-05       Impact factor: 4.418

Review 4.  The involvement of N-methyl-D-aspartate receptor (NMDAR) subunit NR1 in the pathophysiology of schizophrenia.

Authors:  Peijun Ju; Donghong Cui
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-01       Impact factor: 3.848

5.  A novel allosteric modulator of the cannabinoid CB1 receptor ameliorates hyperdopaminergia endophenotypes in rodent models.

Authors:  Catharine A Mielnik; Kim S Sugamori; David B Finlay; Hayley H A Thorpe; Matthieu Schapira; Nirunthan Sivananthan; Chun Kit Li; Vincent M Lam; Sean Harrington; Mostafa H Abdelrahman; Laurent A Trembleau; W McIntyre Burnham; Jibran Y Khokhar; Ali Salahpour; Amy J Ramsey; Michelle Glass; Iain R Greig; Ruth A Ross
Journal:  Neuropsychopharmacology       Date:  2020-10-08       Impact factor: 7.853

Review 6.  The 14-3-3 Protein Family and Schizophrenia.

Authors:  Meaghan Navarrete; Yi Zhou
Journal:  Front Mol Neurosci       Date:  2022-03-14       Impact factor: 5.639

7.  Dysregulated 14-3-3 Family in Peripheral Blood Leukocytes of Patients with Schizophrenia.

Authors:  Ying Qing; Liya Sun; Chao Yang; Jie Jiang; Xuhan Yang; Xiaowen Hu; Donghong Cui; Yifeng Xu; Lin He; Dongmei Han; Chunling Wan
Journal:  Sci Rep       Date:  2016-03-31       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.